Drug related

Host related

High dose

Female gender

Parenteral administration

Age (less frequent in infants and elderly)

Large molecular weight agent

Diseases requiring repeated courses of therapy (such as cystic fibrosis)

Concomitant use of other medications

Genetics (specific HLA types)

Repetitive courses of the same medication.